A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Incyte Corporation
Incyte Corporation
Merck Sharp & Dohme LLC
Ipsen
Deciphera Pharmaceuticals, LLC
Pfizer
Bristol-Myers Squibb
Verastem, Inc.
Polaris Group
Bayer
Incyte Corporation
Incyte Corporation
Epizyme, Inc.
Bayer
Merck Sharp & Dohme LLC
Novartis
Boehringer Ingelheim
Sanofi
Eli Lilly and Company